Electromed, Inc. (ELMD) has a MoatMap StockRank of 96/100 based on Quality (89/100), Value (29/100), and Momentum (72/100) factor scores. The current signal is STRONG BUY. Electromed is a high-quality medical device company specializing in airway clearance therapy. It has excellent gross margins and a solid niche moat, but its growth is highly localized and lacks the massive global macro tailwinds we require for our top 15 positions.
Electromed, Inc. designs, manufactures, and markets airway clearance technologies, primarily its proprietary SmartVest Airway Clearance System, for patients with chronic lung diseases like bronchiectasis. The company operates as a niche market leader in the High Frequency Chest Wall Oscillation (HFCWO) space. Its competitive moat is built on a direct-to-patient distribution model, strong clinical evidence supporting its products, and high reimbursement success rates with insurance providers.
| Price | $36.95 |
| Market Cap | $325M |
| P/E (TTM) | 31.38 |
| P/E (Forward) | 60.20 |
| Price/Book | 6.18 |
| Return on Equity | 21.7% |
| Return on Invested Capital | 22.3% |
| Debt/Equity | 0.17 |
| Gross Margin | 78.4% |
| Operating Margin | 20.3% |
| Revenue Growth | 18.4% |
| Free Cash Flow | $8M |
Electromed, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).